Hans Bishop Biography

Hans Bishop is the CEO of Grail a startup that has raised $1.6 billion to develop a blood test to detect cancer. He has served in this role since June 2019.
Prior to his current appointment he was the CEO of Juno Therapeutics until Celgene in March 2018 for $9 billion. He served as an Executive in Residence at Warburg Pincus a global private equity firm. Previously he acted as EVP and COO for Dendreon Corporation. He has also served as President of Specialty Medicine at Bayer Healthcare and SVP of Global Commercial Operations at Chiron Corporation.
Contact a speaker booking agent to check availability on Hans Bishop and other top speakers and celebrities.

As a renowned expert and highly sought-after speaker, Hans Bishop's expertise is in high demand. To book Hans Bishop for your next event, conference, or workshop, please contact our speaker booking agency. Our experienced team will work closely with you to understand your specific needs and help secure Hans Bishop's participation. With our professional guidance and seamless booking process, you can ensure a memorable and impactful experience for your audience. Don't miss the opportunity to engage your audience with Hans Bishop's compelling insights and inspire positive change within your organization. Fill out the booking request form to take the first step in securing Hans Bishop for your next speaking engagement.